Hidden Disease or Uncertain Risk? Rethinking IMD Diagnosis and Newborn Screening
About this episode
This episode discusses the complexities of diagnosing inherited metabolic disorders and the implications of genomic newborn screening.
Are inherited metabolic disorders more common, and less predictable, than we previously thought? Large-scale genomic studies are identifying adults with disease-associated variants who have escaped diagnosis, sometimes despite lifelong symptoms. At the same time, expanding genomic newborn screening risks identifying children who may remain well for decades or never develop clinically significant disease at all. In this episode Dr Nina Gold, Dr Jessica Gold, and Professor Mirjam Langeveld, explore the tension between missed diagnosis and overdiagnosis and ask, when does knowing more genuinely help? Are Inherited Metabolic Disorders More Common and Less Predictable Than We Thought? N Gold et al https://doi.org/10.1002/jimd.70094 Screening for Life: Perspectives From Adult Metabolic Specialists on Newborn Screening for Inherited Metabolic Diseases. M Langeveld, et al. https://doi.org/10.1002/jimd.70057 Exclusion-based exome sequencing in critically ill adults 18–40 years old has a 24% diagnostic rate and finds racial disparities in access to genetic testing. American Journal of Human Genetics J Gold et al https://www.cell.com/ajhg/fulltext/S0002-9297(25)00238-1 Long-term Penetrance…
More episodes of JIMD Podcasts
- IMD Research Round-Up: Phenylketonuria
- Rapamycin and Pharmacogenomics in Niemann-Pick C
- Shortcast: Clinical Outcomes in Hydroxocobalamin-Treated Patients With Early-Onset Cobalamin C Disease
- Feeding the Microbiome: Rethinking Protein and Propionate in MMA
- Shortcast: Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB
Explore listener stats, chart rankings, contacts and more on the JIMD Podcasts podcast page.